STERIS plc
STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital … Read more
STERIS plc (STE) - Net Assets
Latest net assets as of September 2025: $7.02 Billion USD
Based on the latest financial reports, STERIS plc (STE) has net assets worth $7.02 Billion USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($10.41 Billion) and total liabilities ($3.39 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $7.02 Billion |
| % of Total Assets | 67.46% |
| Annual Growth Rate | 27.99% |
| 5-Year Change | 70.01% |
| 10-Year Change | 117.7% |
| Growth Volatility | 124.26 |
STERIS plc - Net Assets Trend (1991–2025)
This chart illustrates how STERIS plc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for STERIS plc (1991–2025)
The table below shows the annual net assets of STERIS plc from 1991 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | $6.62 Billion | +4.76% |
| 2024-03-31 | $6.32 Billion | +3.75% |
| 2023-03-31 | $6.09 Billion | -6.99% |
| 2022-03-31 | $6.54 Billion | +68.18% |
| 2021-03-31 | $3.89 Billion | +14.23% |
| 2020-03-31 | $3.41 Billion | +6.93% |
| 2019-03-31 | $3.19 Billion | -0.98% |
| 2018-03-31 | $3.22 Billion | +14.49% |
| 2017-03-31 | $2.81 Billion | -7.53% |
| 2016-03-31 | $3.04 Billion | +183.04% |
| 2015-03-31 | $1.07 Billion | +3.11% |
| 2014-03-31 | $1.04 Billion | +9.95% |
| 2013-03-31 | $946.98 Million | +15.11% |
| 2012-03-31 | $822.66 Million | +4.31% |
| 2011-03-31 | $788.66 Million | +4.53% |
| 2010-03-31 | $754.49 Million | +5.12% |
| 2009-03-31 | $717.74 Million | +1.59% |
| 2008-03-31 | $706.48 Million | -8.76% |
| 2007-03-31 | $774.29 Million | +5.95% |
| 2006-03-31 | $730.83 Million | -3.28% |
| 2005-03-31 | $755.64 Million | +11.28% |
| 2004-03-31 | $679.06 Million | +19.23% |
| 2003-03-31 | $569.53 Million | +16.91% |
| 2002-03-31 | $487.14 Million | +14.79% |
| 2001-03-31 | $424.38 Million | +0.78% |
| 2000-03-31 | $421.09 Million | -3.40% |
| 1999-03-31 | $435.90 Million | +21.44% |
| 1998-03-31 | $358.95 Million | +21.80% |
| 1997-03-31 | $294.70 Million | -3.09% |
| 1996-03-31 | $304.10 Million | +581.84% |
| 1995-03-31 | $44.60 Million | +26.70% |
| 1994-03-31 | $35.20 Million | +30.86% |
| 1993-03-31 | $26.90 Million | +407.55% |
| 1992-03-31 | $5.30 Million | +253.33% |
| 1991-03-31 | $1.50 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to STERIS plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 248183000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $2.48 Billion | 37.49% |
| Common Stock | $4.42 Billion | 66.94% |
| Other Comprehensive Income | $-292.34 Million | -4.43% |
| Total Equity | $6.60 Billion | 100.00% |
STERIS plc Competitors by Market Cap
The table below lists competitors of STERIS plc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
MongoDB, Inc.
LSE:0KKZ
|
$21.53 Billion |
|
Bayer AG
PINK:BAYZF
|
$21.61 Billion |
|
Oriental Land Co. Ltd
PINK:OLCLF
|
$21.62 Billion |
|
SBI Life Insurance Company Limited
NSE:SBILIFE
|
$21.64 Billion |
|
Williams-Sonoma Inc
NYSE:WSM
|
$21.50 Billion |
|
Semiconductor Manufacturing International Corporation
F:MKN2
|
$21.49 Billion |
|
AerCap Holdings NV
NYSE:AER
|
$21.49 Billion |
|
Volkswagen AG Non-Vtg Pfd.
WAR:VOW
|
$21.44 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in STERIS plc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 6,302,164,000 to 6,603,405,000, a change of 301,241,000 (4.8%).
- Net income of 614,641,000 contributed positively to equity growth.
- Dividend payments of 219,875,000 reduced retained earnings.
- Share repurchases of 211,321,000 reduced equity.
- Other comprehensive income increased equity by 36,319,000.
- Other factors increased equity by 81,477,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $614.64 Million | +9.31% |
| Dividends Paid | $219.88 Million | -3.33% |
| Share Repurchases | $211.32 Million | -3.2% |
| Other Comprehensive Income | $36.32 Million | +0.55% |
| Other Changes | $81.48 Million | +1.23% |
| Total Change | $- | 4.78% |
Book Value vs Market Value Analysis
This analysis compares STERIS plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.30x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 1956.66x to 3.30x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1991-03-31 | $0.11 | $220.13 | x |
| 1992-03-31 | $0.27 | $220.13 | x |
| 1993-03-31 | $0.79 | $220.13 | x |
| 1994-03-31 | $1.01 | $220.13 | x |
| 1995-03-31 | $1.27 | $220.13 | x |
| 1996-03-31 | $8.47 | $220.13 | x |
| 1997-03-31 | $4.34 | $220.13 | x |
| 1998-03-31 | $5.22 | $220.13 | x |
| 1999-03-31 | $6.16 | $220.13 | x |
| 2000-03-31 | $6.02 | $220.13 | x |
| 2001-03-31 | $6.44 | $220.13 | x |
| 2002-03-31 | $6.85 | $220.13 | x |
| 2003-03-31 | $8.03 | $220.13 | x |
| 2004-03-31 | $9.61 | $220.13 | x |
| 2005-03-31 | $10.81 | $220.13 | x |
| 2006-03-31 | $10.61 | $220.13 | x |
| 2007-03-31 | $11.78 | $220.13 | x |
| 2008-03-31 | $10.99 | $220.13 | x |
| 2009-03-31 | $12.07 | $220.13 | x |
| 2010-03-31 | $12.68 | $220.13 | x |
| 2011-03-31 | $13.09 | $220.13 | x |
| 2012-03-31 | $13.93 | $220.13 | x |
| 2013-03-31 | $16.09 | $220.13 | x |
| 2014-03-31 | $17.43 | $220.13 | x |
| 2015-03-31 | $17.88 | $220.13 | x |
| 2016-03-31 | $42.69 | $220.13 | x |
| 2017-03-31 | $32.64 | $220.13 | x |
| 2018-03-31 | $37.54 | $220.13 | x |
| 2019-03-31 | $37.27 | $220.13 | x |
| 2020-03-31 | $39.78 | $220.13 | x |
| 2021-03-31 | $45.30 | $220.13 | x |
| 2022-03-31 | $66.44 | $220.13 | x |
| 2023-03-31 | $60.72 | $220.13 | x |
| 2024-03-31 | $63.43 | $220.13 | x |
| 2025-03-31 | $66.65 | $220.13 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently STERIS plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 9.31%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 11.26%
- • Asset Turnover: 0.54x
- • Equity Multiplier: 1.54x
- Recent ROE (9.31%) is above the historical average (7.05%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1993 | 9.29% | 9.36% | 0.86x | 1.15x | $-190.00K |
| 1994 | 17.90% | 13.76% | 1.07x | 1.21x | $2.78 Million |
| 1995 | -84.53% | -6.91% | 9.94x | 1.23x | $-42.16 Million |
| 1996 | 13.42% | 7.63% | 0.90x | 1.95x | $10.39 Million |
| 1997 | -10.38% | -5.20% | 1.09x | 1.83x | $-60.07 Million |
| 1998 | 18.25% | 9.10% | 0.98x | 2.04x | $29.60 Million |
| 1999 | 19.48% | 10.64% | 0.92x | 1.99x | $41.31 Million |
| 2000 | 2.49% | 1.38% | 0.84x | 2.15x | $-31.62 Million |
| 2001 | 0.31% | 0.16% | 0.95x | 1.99x | $-41.12 Million |
| 2002 | 9.48% | 5.33% | 1.03x | 1.73x | $-2.51 Million |
| 2003 | 13.95% | 8.17% | 1.09x | 1.57x | $22.48 Million |
| 2004 | 13.85% | 9.13% | 0.97x | 1.57x | $26.17 Million |
| 2005 | 11.38% | 7.95% | 0.91x | 1.57x | $10.42 Million |
| 2006 | 9.62% | 6.06% | 0.98x | 1.63x | $-2.79 Million |
| 2007 | 10.61% | 6.86% | 0.99x | 1.56x | $4.73 Million |
| 2008 | 10.92% | 6.09% | 1.02x | 1.75x | $6.49 Million |
| 2009 | 15.42% | 8.52% | 1.07x | 1.70x | $38.91 Million |
| 2010 | 17.04% | 10.21% | 1.02x | 1.64x | $53.10 Million |
| 2011 | 6.51% | 4.25% | 0.85x | 1.81x | $-27.49 Million |
| 2012 | 16.57% | 9.68% | 1.00x | 1.71x | $53.97 Million |
| 2013 | 16.89% | 10.65% | 0.85x | 1.86x | $65.28 Million |
| 2014 | 12.43% | 7.98% | 0.86x | 1.81x | $25.32 Million |
| 2015 | 12.58% | 7.30% | 0.88x | 1.96x | $27.70 Million |
| 2016 | 3.64% | 4.95% | 0.42x | 1.76x | $-193.13 Million |
| 2017 | 3.91% | 4.21% | 0.53x | 1.75x | $-171.04 Million |
| 2018 | 9.04% | 11.10% | 0.50x | 1.62x | $-30.82 Million |
| 2019 | 9.54% | 10.93% | 0.55x | 1.59x | $-14.53 Million |
| 2020 | 11.97% | 13.45% | 0.56x | 1.59x | $66.99 Million |
| 2021 | 10.21% | 12.79% | 0.47x | 1.69x | $8.25 Million |
| 2022 | 3.73% | 5.77% | 0.37x | 1.75x | $-409.35 Million |
| 2023 | 1.76% | 2.36% | 0.42x | 1.78x | $-501.69 Million |
| 2024 | 6.00% | 7.36% | 0.46x | 1.76x | $-251.98 Million |
| 2025 | 9.31% | 11.26% | 0.54x | 1.54x | $-45.70 Million |
Industry Comparison
This section compares STERIS plc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| STERIS plc (STE) | $7.02 Billion | 9.29% | 0.48x | $21.52 Billion |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |